JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trendelenburg, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trendelenburg, U.
Journal of Pharmacology And Experimental Therapeutics, Vol. 154, Issue 3, 418-425, 1966
Copyright © 1966 by American Society for Pharmacology and Experimental Therapeutics


OBSERVATIONS ON THE GANGLION-STIMULATING ACTION OF ANGIOTENSIN AND BRADYKININ

U. Trendelenburg 1

1 Department of Pharmacology, Harvard Medical School, Boston, Massachusetts

Contractions of the nictitating membrane of the spinal cat were elicited by intraarterial injections of angiotensin and bradykinin to the superior cervical ganglion. The ganglionic effects of the two polypeptides were found to be similar to those of other non-nicotinic agents. 1) A preceding period of preganglionic stimulation facilitated ganglionic responses to the polypeptides. 2) Intravenous injections of cocaine and morphine antagonized the effects of the polypeptides on ganglia. 3) Depolarization of ganglia by nicotine abolished ganglionic responses to both polypeptides. However, during the late, non-depolarizing phase of the block by nicotine, there was facilitation of ganglionic responses to angiotensin, while responses to bradykinin were reduced. Subsequent intravenous injections of hexamethonium restored ganglionic responses to both polypeptides to normal. Although there are minor differences in the actions of angiotensin and bradykinin, both agents appear to belong to the group of non-nicotinic ganglion-stimulating agents.

Submitted on April 11, 1966
Accepted on June 15, 1966




This article has been cited by other articles:


Home page
J. Neurosci.Home page
T. Scholze, E. Moskvina, M. Mayer, H. Just, H. Kubista, and S. Boehm
Sympathoexcitation by Bradykinin Involves Ca2+-Independent Protein Kinase C
J. Neurosci., July 15, 2002; 22(14): 5823 - 5832.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1966 by the American Society for Pharmacology and Experimental Therapeutics.